Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Hypertensive Heart Disease
NCT00865501Phase 3Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Mar 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in primary hypertension, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started Mar 2008; status: completed.
02
Drugs
spironolactone
03
Conditions
primary hypertension
Beyond the preview
Go deeper on NCT00865501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865501.